NCT06695845 2026-02-25A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsJazz PharmaceuticalsPhase 2 Recruiting200 enrolled
NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT06519110 2024-07-25CVL009-C2001Convalife (Shanghai) Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT00637637 2013-08-12External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesNational Cancer Institute (NCI)Phase 2 Unknown60 enrolled
NCT00019331 2013-06-20Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed